全球核酸分離純化市場規模、佔有率、趨勢及成長分析報告（2026-2034）

核酸分離純化市場預計將從 2025 年的 63.8 億美元成長到 2034 年的 129.9 億美元，2026 年至 2034 年的複合年成長率為 8.21%。

對分子診斷、基因組學研究和個人化醫療的日益重視正推動全球核酸分離純化市場顯著擴張。這些技術對於從生物樣本中提取DNA和RNA至關重要，可用於PCR、定序和克隆等下游製程。新冠疫情加速了對可靠萃取試劑盒、自動化系統和以微珠為基礎純化方法的需求，從而加強了全球實驗室基礎設施建設。

關鍵成長要素包括次世代定序(NGS) 的廣泛應用、感染疾病和遺傳性疾病的增加，以及生物技術和製藥領域研發投入的擴大。自動化和高通量平台的引入提高了臨床和實驗室環境的效率和可重複性。政府對基因組學計劃的資助以及樣本製備技術的進步，進一步推動了學術界、診斷和工業界的市場成長。

由於精準醫療、液態生物檢體和基因治療等領域的持續需求，未來前景十分樂觀。小型化、快速化和自動化提取解決方案有望廣泛應用，尤其是在照護現場。新興經濟體對分子檢測能力的投資將創造新的機會。然而，成本敏感度和對標準化通訊協定的需求可能會影響競爭格局。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球核酸分離純化市場：依產品分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 裝置

第5章 全球核酸分離純化市場：依類型分類

• 市場分析、洞察與預測
• RNA分離與純化
• mRNA分離純化
• 微型RNA的分離與純化
• 總RNA分離純化
• 其他RNA分離和純化類型
• DNA分離與純化
• 基因組DNA的分離與純化
• 質體DNA的分離與純化
• 病毒DNA的分離與純化
• 其他DNA分離純化類型

第6章 全球核酸分離純化市場：依方法分類

• 市場分析、洞察與預測
• 磁珠
• 基於列
• 基於試劑
• 其他方法

第7章 全球核酸分離純化市場：依應用領域分類

• 市場分析、洞察與預測
• 診斷
• 藥物發現與開發
• 精準醫療
• 其他用途

第8章：全球核酸分離純化市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診斷中心
• 製藥和生物技術公司
• 受託研究機構
• 其他最終用戶

第9章 全球核酸分離純化市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Qiagen NV
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Danaher Corporation
  • F. Hoffmann La Roche Ltd
  • Merck KGaA
  • Agilent Technologies Inc
  • Bio-Rad Laboratories
  • Takara Bio Inc
  • Promega Corporation
  • New England Biolabs
  • Abcam Plc
  • PCR Biosystems

The Nucleic Acid Isolation & Purification Market size is expected to reach USD 12.99 Billion in 2034 from USD 6.38 Billion (2025) growing at a CAGR of 8.21% during 2026-2034.

The global nucleic acid isolation and purification market has expanded significantly due to rising molecular diagnostics, genomics research, and personalized medicine initiatives. These technologies are essential for extracting DNA and RNA from biological samples for downstream applications such as PCR, sequencing, and cloning. The COVID-19 pandemic accelerated demand for reliable extraction kits, automation systems, and magnetic bead-based purification methods, strengthening laboratory infrastructure worldwide.

Key drivers include growing adoption of next-generation sequencing (NGS), increasing prevalence of infectious and genetic diseases, and expansion of biotech and pharmaceutical R&D. Automation and high-throughput platforms have improved efficiency and reproducibility in clinical and research laboratories. Government funding for genomics projects and advancements in sample preparation technologies further stimulate market growth across academic, diagnostic, and industrial sectors.

Future prospects are promising, with sustained demand from precision medicine, liquid biopsy, and gene therapy development. Miniaturized, rapid, and automated extraction solutions will gain traction, especially in point-of-care diagnostics. Emerging economies investing in molecular testing capacity will create additional opportunities. However, cost sensitivity and the need for standardized protocols may influence competitive dynamics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents & Kits
• Instruments

By Type

• Rna Isolation & Purification
• Mrna Isolation & Purification
• Mirna Isolation & Purification
• Total Rna Isolation & Purification
• Other Rna Isolation & Purification Types
• Dna Isolation & Purification
• Genomic Dna Isolation & Purification
• Plasmid Dna Isolation & Purification
• Viral Dna Isolation & Purification
• Other Dna Isolation & Purification Types

By Method

• Magnetic Beads
• Column-Based
• Reagent-Based
• Other Methods

By Application

• Diagnostics
• Drug Discovery & Development
• Precision Medicine
• Other Applications

By End-Use

• Hospitals And Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Other End-Users

COMPANIES PROFILED

• Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corporation, F Hoffmann La Roche Ltd, Merck KGaA, Agilent Technologies Inc, BioRad Laboratories, Takara Bio Inc, Promega Corporation, New England Biolabs, Abcam plc, PCR Biosystems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Mrna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Mirna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Total Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Rna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Genomic Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Plasmid Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Viral Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Other Dna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method
• 6.2. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Column-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Reagent-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospitals And Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Type
  • 9.2.3 By Method
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Type
  • 9.3.3 By Method
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Type
  • 9.4.3 By Method
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Type
  • 9.5.3 By Method
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Type
  • 9.6.3 By Method
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Qiagen N.V
  • 11.2.2 Thermo Fisher Scientific Inc
  • 11.2.3 Illumina Inc
  • 11.2.4 Danaher Corporation
  • 11.2.5 F. Hoffmann La Roche Ltd
  • 11.2.6 Merck KGaA
  • 11.2.7 Agilent Technologies Inc
  • 11.2.8 Bio-Rad Laboratories
  • 11.2.9 Takara Bio Inc
  • 11.2.10 Promega Corporation
  • 11.2.11 New England Biolabs
  • 11.2.12 Abcam Plc
  • 11.2.13 PCR Biosystems